Jain Global »

BioCryst Pharmaceuticals shares owned by Jain Global

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Jain Global from 13F filings

Historical chart of Jain Global investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Jain Global consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Jain Global

Quarter filed Position value Share count Share price at filing
2025-12-31 $581k 75k 7.80
2025-06-30 $2.2M 241k 8.96
2024-12-31 $649k 86k 7.52

More positions owned by Jain Global

Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Vaneck Etf Trust Gold Miners Etf (GDX)
Tesla Motors (TSLA)
Boeing Company (BA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation (NVDA)
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr State Street Fin Call Option (XLF)
Spdr Series Trust State Street Spd Call Option (KRE)

View all positions for Jain Global

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
Alkeon Capital Management
UBS Group
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Nuveen
Goldman Sachs Group
Jennifer Ranahan
Eversept Partners
Bnp Paribas Arbitrage, Snc

View all funds holding BioCryst Pharmaceuticals